Eric Sabo
Founder & CEO
With deep experience in the life sciences and precision fermentation, Eric saw the original need for Growth Curve. He leads the charge and ensures client programs succeed.
Questions need to be answered, conditions need to be optimized, processes need to be validated, execution needs to be de-risked.
We understand the difficulties of balancing the need for R&D work with the economic realities of high growth ventures and novel product lines.
As a company born from seasoned, multi-time founders, we built Growth Curve to solve this exact problem. Providing clients with a predictable, cost effective way to advance their synthetic biology programs as true value drivers of their business, not costly science projects.
Operators who have built technologies, grown companies, and carried programs from the bench to production.
With deep experience in the life sciences and precision fermentation, Eric saw the original need for Growth Curve. He leads the charge and ensures client programs succeed.
An operator and entrepreneur who has founded and scaled multiple companies across industries. Ben focuses on strategy and execution, helping Growth Curve build and grow effectively.
Bringing a heavy technology, AI, and science background, Hunter drives scientific process optimization and data driven client outcomes.
The facility, the framework, and the philosophy behind every program we take on.
An R&D-grade precision fermentation facility specializing in BSL-1 microbial hosts. Our framework incorporates GMP-informed documentation, defined process controls, and rigorous analytical reporting, so programs transition cleanly into regulated environments.
As engineers and operators with deep experience across microbial systems, we carry programs from strain optimization through pilot execution, and, when you're ready, into the hand-off and management of large-scale manufacturing. One accountable partner across the entire chain.
Three convictions that shape how we take on work. Open any one to see what it means for your program.
The most expensive programs are the ones kept alive too long. Testing the riskiest assumption first is not pessimism; it is the cheapest insurance a young product line can buy.
You get an early, honest read on feasibility and a clean data package behind every go / no-go. And when a program is not going to scale, we say so, because saving you two quarters and a round of capital is worth more to us than billing them.
The best partnerships run on a shared picture of what success looks like. We keep our incentives pointed at the same target as yours, so every recommendation, milestone, and trade-off is measured against the outcome you actually care about. Alignment is something we build deliberately and revisit often, not a box we check once.
We define clear, specific outcomes together at the outset and keep them in view at every stage, so you get what you expect on the timelines you need. Every decision arrives with the reasoning and the data behind it, and the work stays inside the economic constraints your program actually has to live within.
A one-off success that lives in one person's hands is a liability waiting to surface. Real progress comes from turning what works into a documented, repeatable system, so every run builds on the last instead of rediscovering it. Rigor is not bureaucracy; it is what lets a process survive contact with scale.
Every stage of your program lives in defined protocols, controls, and data rather than tribal knowledge, so results hold up under scrutiny and travel cleanly into a manufacturing environment. When you scale, you carry a system anyone can run, not a recipe only we remember.